Correlation of Gut Microbiota, Vitamin D Status, and Pulmonary Function Tests in Children With Cystic Fibrosis

Hadeel Albedewi1, Iman Bindayel1, Ahmed Albarrag2

  • 1Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.

Insights

Children with cystic fibrosis have lower vitamin D and altered gut bacteria. Optimal vitamin D levels correlate with higher beneficial gut bacteria and improved lung function in CF patients.

Area of Science:

  • Pediatric Gastroenterology
  • Pulmonology
  • Microbiome Research

Background:

  • Children with cystic fibrosis (CF) often exhibit low vitamin D levels and dysbiotic gut microbiota.
  • Gut dysbiosis in CF may exacerbate respiratory inflammation.
  • Vitamin D and gut microbiota interactions are increasingly recognized.

Purpose of the Study:

  • To investigate the relationship between serum 25-hydroxyvitamin D [25(OH)D] levels, pulmonary function, and gut bacterial composition in children with CF.

Main Methods:

  • A cross-sectional study included 35 children with CF and 24 controls.
  • Serum 25(OH)D was measured, and gut microbiota composition was analyzed using real-time PCR.
  • Pulmonary function tests (spirometry) were performed.

Main Results:

  • Children with CF had significantly lower serum 25(OH)D compared to controls (P=0.026).
  • Optimal 25(OH)D levels in CF patients correlated with increased levels of Bacteroidetes, Firmicutes, and total bacteria (P≤0.022).
  • Higher Firmicutes levels were associated with milder forced expiratory volume in 1 second (FEV1) (P=0.032).

Conclusions:

  • Findings suggest a link between vitamin D status, gut microbiota, and respiratory health in pediatric CF.
  • Modulating gut microbiota may offer a therapeutic strategy to improve respiratory outcomes in CF.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
357
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
220
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
431
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
403
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
563